Influence of gender and place of residence differences on the evolution and mortality of ischemic cardiopathy in Catalonia: a population-based study
e202301004
Keywords:
Metabolic syndrome, Cardiovascular diseases, Deprivation, Poverty, Inequalities, Cardiac arrest, Health services, Gender, Phenotypes, Risk factorsAbstract
BACKGROUND // Some bibliography supports a diagnostic and therapeutic delay in women with high cardiovascular risk. The objective of this paper was to know the incidence of cardiovascular disease (CVD) and mortality in a cohort with Metabolic Syndrome (MetS); analyze possible differences in gender and place of residence, regarding the performance of primary angioplasties in patients with ischemic heart disease (IHD).
METHODS // Population cohort study, with SIDIAP database (Sistema de Información para la Investigación en Atención Primaria), in primary care in Catalonia. We selected people of both sexes, between 35-75 years old, exempt from CVD at the beginning (2009), fulfilling MetS criteria (NCEP-ATPIII-National Cholesterol Education Program-Adult Treatment Panel III- criteria diagnoses). We performed descriptive statistics, and ANOVA and Chi-square test to evaluate differences between variables.
RESULTS // 167,673 people met MetS criteria (5.2% of the population), 105,969 men (63.2%). 22% of the population belonged to rural areas. Those urban areas with the most socioeconomic differences (urban-1 and urban-5) exhibited the highest incidences of CVD and IHD. We registered 51,129 CVD (30.7%) of which 8,889 were acute myocardial infarctions (AMI) (5,3%) and 24,284 were IHD (14,5%). 1.758 primary angioplasties procedures were performed, 1,467 in men and 291 in women, representing, respectively, 4.4% and 0.9% (p<0.005).
CONCLUSIONS // The incidence of IHD and AMI in subjects with MetS is high in Catalonia. There is a difference in the angioplasties performed, according to sex and place of residence. Probably a practical implication would be to detect IHD in time in women with MetS, so that they can benefit from revascularization therapy in the same way as men.
Downloads
References
Rohfls I, García M, Gavaldà L, Medrano MJ, Juvinyà MD, Baltasar A et al. Género y cardiopatía isquémica. Gac Sanit 2004;18(Supl 2):55-64
Instituto Nacional de Estadística [Sede web]. Encuesta nacional de salud 2017. Madrid: Instituto Nacional de Estadística; 2018. [consultado el 01/05/2021]
Healy B. The Yentl syndrome. N Engl J Med 1991; 325:274-276.
Merz CN. The Yentl syndrome is alive and well. Eur Heart J 2011; 32(11):1313-1315.
Elízaga Corrales J. Angioplasty is elective reperfusion therapy in the treatment of acute myocardial infarction. Arguments in favor. Rev Esp Cardiol. 1998 Dec;51(12):939-947.
Sambola A, Elola FJ, Ferreiro JL, Murga N, Rodríguez-Padial L, Fernández C et al. Impact of sex differences and network systems on the in-hospital mortality of patients with ST-segment elevation acute myocardial infarction. Rev Esp Cardiol (Engl Ed). 2020 Sep 2:S1885-5857(20)30361-3.
Bucholz EM, Butala NM, Rathore SS, Dreyer RP, Lansky AJ, Krumholz HM. Sex differences in long-term mortality after myocardial infarction: a systematic review. Circulation. 2014;130:757-767.
Alabas OA, Gale CP, Hall M, Rutherford MJ, Szummer K, Sederholm S et al. Sex differences in treatments, relative survival, and excess mortality following acute myocardial infarction: national cohort study using the SWEDEHEART registry. J Am Heart Assoc. 2017;6:e007123.
Cenko E, Yoon J, Kedev S, Stankovic G, Vasiljević Z, Krljanac G. Sex differences in outcomes after STEMI Effect modification by treatment strategy and age. JAMA Intern Med. 2018;178:632-639.
Wilkinson C, Bebb O, Dondo TB, Munyombwe T, Casadei B, Clarke S et al. Sex differences in quality indicator attainment for myocardial infarction: a nationwide cohort study. Heart. 2019;10:516-523.
Aguilar MD, Lázaro P, Fitch K, Luengo S. Gender differences in clinical status at time of coronary revascularisation in Spain. J Epidemiol Community Health. 2002 Jul;56(7):555-559.
Domínguez-Berjón MF, Borrell C, Cano-Serral G, Esnaola S, Nolasco A, Pasarín MI et al. Constructing a deprivation index based on census data in large Spanish cities (the MEDEA project). Gac Sanit 2008 May-Jun;22(3):179-187.
Caro-Mendivelso J, Elorza-Ricart JM, Hermosilla E, Méndez-Boo L, García-Gil M, Prieto-Alhambra D et al. Associations between socioeconomic index and mortality in rural and urban small geographic areas of Catalonia, Spain: Ecological study. Journal of Epidemiological Research 2016. Vol 2, No 1:80-86.
La Rosa E, Le Clésiau H, Valensi P. Metabolic syndrome and psychosocial deprivation. Data collected from a Paris suburb. Diabetis Metab. 2008 Apr; 34(2):155-161.
Gandarillas AM, Domínguez-Berjón MF, Soto MJ. Increase in socioeconomicinequalities in mortality in a Southern European region: a small-area ecological study. J Public Health (Oxf). 2015 Aug 11. pii: fdv101. PubMed PMID: 26265477
Cabré Vila JJ, Ortega Vila Y, Aragonès Benaiges E, Basora Gallisà J, Araujo Bernardo Á, Solà Alberich R. Impacto del lugar de residencia sobre la presentación de eventos cardiovasculares y mortalidad por toda causa, en una cohorte afecta de síndrome metabólico. Rev Esp Salud Publica 2018, Vol 92: 1-12.
Borrell C, Marí-Dell’Olmo M, Serral G, Martínez- Beneito M, Gotsens M, otros miembros MEDEA. Inequalities in mortality in small areas of eleven Spanish cities (the multicenter MEDEA project). Health & Place, 2010, (16): 703-711.
Ibarra-Castillo C, Guisado-Clavero M, Violán-Fors C, Pons M, López T, Rosó-Llorach A. Survival in relation to multimorbidity patterns in older adults in primary care in Barcelona, Spain (2010–2014): a longitudinal study based on electronic health records. J Epidemiol Com- munity Health. 2018 Mar;72(3):185-192. doi: https://doi.org/10.1136/ jech-2017-209984. Epub 12 enero 2018.
Ramsay SE, Morris RW, Whincup PH, Subramanian SV, Papacosta AO, Lennon LT et al. The influence of neighbourhood-level socioeconomic deprivation on cardiovascular disease mortality in older age: longitudinal multilevel analyses from a cohort of older British men. J Epidemiol Community Health 2015 Dec; 69(12):1224-1231.
Thorne K, Williams JG, Akbari A, Roberts SE. The impact of social deprivationon mortality following acute myocardial infarction, stroke or subarachnoid haemorrhage: a record linkage study. BMC Cardiovasc Disord. 2015 Jul 18;15:71.
Cabré JJ, Martín F, Costa B, Piñol JL, Llor JL, Ortega Y et al. Metabolic syndrome as a cardiovascular disease risk factor: patients evaluated in primary care. BMC Public Health 2008; 8:251
Moebus S, Balijepalli C, Lösch C, Göres L, von Stritzky B, Bramlage P et al. Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study. Cardiovasc Diabetol. 2010 Aug 9;9:34. doi: https://doi.org/10.1186/1475-2840-9-34
Girman CJ, Dekker JM, Rhodes T, Nijpels G, Stehouwer CD, Bouter LM et al. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study. Am J Epidemiol. 2005 Sep 1;162(5):438-47. Epub 2 agosto 2005.
Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A et al. Comorbidity with metabolic syndrome in a general population. Diabetes Care. 2008 Dec;31(12):2368-2373.
Díez-Roux AV, Kiefe CI, Jacobs DR Jr, Haan M, Jackson SA, Nieto FJ et al. Area characteristics and individual-level socioeconomic position indicators in three population-based epidemiologic studies. Ann Epidemiol 2001 Aug; 11(6):395-405.
Langenberg C, Kuh D, Wadsworth ME, Brunner E, Hardy R. Social circumstances and education: life course origins of social inequalities in metabolic risk in a prospective national birth cohort. Am J Public Health. 2006 Dec; 96(12): 2216-2221.
La Rosa E, Le Clésiau H, Valensi P. Metabolic syndrome and psychosocial deprivation. Data collected from a Paris suburb. Diabetes Metab. 2008 Apr; 34(2):155-159
Guize L, Jaffiol C, Guéniot M, Bringer J, Giudicelli C, Tramoni M et al. Diabetes and socio-economic deprivation. A study in a large French population. Bull Acad Natl Med. 2008 Dec; 192(9):1707-1723.
Voss LD, Hosking J, Metcalf BS, Jeffery AN, Frémeaux AE, Wilkin TJ. Metabolic risk in contemporary children is unrelated to socio-economic status: longitudinal study of a UK urban population (EarlyBird 42). Pediatr Diabetes. 2014 May; 15(3):244-251
Non AL, Rewak M, Kawachi I, Gilman SE, Loucks EB, Appleton AA et al. Childhood social disadvantage, cardiometabolic risk, and chronic disease in adulthood. Am J Epidemiol. 2014 Aug 1;180(3):263-271.
Keita AD, Judd SE, Howard VJ, Carson AP, Ard JD, Fernández JR. Associations ofneighborhood area level deprivation with the metabolic syndrome and inflammation among middle- and older-age adults. BMC Public Health. 2014 Dec 23; 14:1319.
Khan SA, Jackson RT, Momen B. The Relationship between Diet Quality and Acculturation of Immigrated South Asian American Adults and Their Association with Metabolic Syndrome. PLOS One 2016; 11(6).
Ortega Y, Aragonès E, Piñol JL, Basora J, Araujo A, Cabré JJ. Impacte de l’estrés en la sindrome metabòlica. Cinc anys de seguiment del Projecte StreX. Butlletí At Prim Catalunya 2017; http://www.butlleti.cat/ca/Vol35/iss3/2 [artículo en catalán].
Ortega Y, Aragonès E, Piñol JL, Basora J, Araujo A, Cabré JJ. Impact of depression and/or anxiety on the presentation of cardiovascular events in a cohort with metabolic syndrome. StreX project: Five years of follow-up. Prim Care Diabetes 2018; 12: 163-171.
García-Gil MM, Hermosilla E, Prieto-Alhambra D, Fina F, Rosell M, Ramos R et al. Construction and validation of a scoring system for the selection of high-quality data in a Spanish population primary care database (SIDIAP). Inform Prim Care. 2011;19(3):135-145.
Alberti KGMM, Zimmet P, Shaw J for the IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-A new worldwide definition. Lancet 2005; 366, 9491: 1059-1062.
Institut d’ Estadística de Catalunya. URL: http://www.idescat.cat/ [consultado 02/05/2021].
Girman CJ, Dekker JM, Rhodes T, Nijpels G, Stehou- wer CD, Bouter LM et al. An exploratory analysis of criteria for the metabolic syndrome and its prediction of long-term cardiovascular outcomes: the Hoorn study. Am J Epidemiol. 2005 Sep 1;162(5):438-47. Epub 2 agosto 2005.
Moebus S, Balijepalli C, Lösch C, Göres L, von Stritzky B, Bramlage P et al. Age and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome-A cross-sectional study. Cardiovasc Diabetol. 2010 Aug 9;9:34.
Rubini M, Reiter M, Twerenbold R, Reichlin T, Wildi K, Haaf P et al. Sex-specific chest pain characteristics in the early diagnosis of acute myocardial infarction. JAMA Intern Med. 2014;174:241-249.
Vogel B, Farhan S, Hahne S, Kozanli I, Kalla K, Freynhofer MK et al. Sex-related differences in baseline characteristics, manage- ment and outcome in patients with acute coronary syndrome without ST-segment elevation. Eur Heart J Acute Cardiovasc Care 2016;5:347-353.
Sabbag A, Matetzky S, Gottlieb S, Fefer P, Kohanov O, Atar S et al. Recent temporal trends in the presentation, management, and outcome of women hospitalized with acute coronary syndromes. Am J Med 2015;128:380-388.
Nielsen S, Bjorck L, Berg J, Giang KW, Zverkova Sandstrom T, Falk K et al. Sex-specific trends in 4-year survival in 37 276 men and women with acute myocardial infarction before the age of 55 years in Sweden, 1987-2006: a register-based cohort study. BMJ Open 2014;4:e004598.
Aguilar MD. Factores de riesgo cardiovascular desde la perspectiva de sexo y género. Rev Col Cardiol 2018; 25 (1): 8-12.
Aguilar MD, Lázaro P, Fitch K, Luengo S. Gender differences in clinical status at time of coronary revascularisation in Spain. J Epidemiol Community Health. 2002 Jul;56(7):555-559.
Published
How to Cite
Issue
Section
Categories
License
Copyright (c) 2023 Marta Pepió Espuny , Yolanda Ortega Vila , Enric Aragonès Benaiges, José Fernández Sáez, Meritxell Pallejà Millán, Joan-Josep Cabré Vila
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Usted es libre de:
Compartir — copiar y redistribuir el material en cualquier medio o formato.
La licenciante no puede revocar estas libertades en tanto usted siga los términos de la licencia.
Bajo los siguientes términos:
Atribución — Usted debe dar crédito de manera adecuada , brindar un enlace a la licencia, e indicar si se han realizado cambios. Puede hacerlo en cualquier forma razonable, pero no de forma tal que sugiera que usted o su uso tienen el apoyo de la licenciante.
NoComercial — Usted no puede hacer uso del material con propósitos comerciales.
SinDerivadas — Si remezcla, transforma o crea a partir del material, no podrá distribuir el material modificado.
No hay restricciones adicionales — No puede aplicar términos legales ni medidas tecnológicas que restrinjan legalmente a otras a hacer cualquier uso permitido por la licencia.
Avisos:
No tiene que cumplir con la licencia para elementos del material en el dominio público o cuando su uso esté permitido por una excepción o limitación aplicable.
No se dan garantías. La licencia podría no darle todos los permisos que necesita para el uso que tenga previsto. Por ejemplo, otros derechos como publicidad, privacidad, o derechos morales pueden limitar la forma en que utilice el material.
